Physician profile
Benny L Wright
NPI 1992894539
$4,515.66
in general payments reported to CMS, 2019-2025
31 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $317 · 2021: $568 · 2022: $452 · 2023: $431 · 2024: $1,430 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,861 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,860.81 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $593.19 | 2019-2023 | Liletta |
| Mimedx Group, INC. | $488.28 | 2024-2025 | |
| Exact Sciences Corporation | $419.57 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Corcept Therapeutics | $312.67 | 2024-2025 | Korlym |
| Astellas Pharma US INC | $308.98 | 2024-2025 | Veozah |
| Biogen, INC. | $293.12 | 2024-2025 | Zurzuvae |
| Organon LLC | $206.02 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $192.84 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $179.57 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $165.34 | 2022-2025 | |
| Hologic Sales and Service, LLC | $154.13 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Evofem Biosciences, INC. | $123.48 | 2021-2025 | Phexxi, Solosec, Phexx |
| Smith+Nephew, INC. | $121.46 | 2020-2024 | Collagenase Santyl, Iodosorb Ointment 40g USA, Stravix Pl |
| Merck Sharp & Dohme LLC | $119.06 | 2019-2023 | Gardasil 9 |
| Pfizer INC. | $96.09 | 2022-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $86.45 | 2024-2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $81.98 | 2024 | |
| Coloplast Corp | $75.21 | 2024 | |
| Agile Therapeutics, INC. | $69.73 | 2022-2024 | Twirla |
| Lupin INC. | $62.62 | 2019-2020 | |
| Minerva Surgical, INC | $61.28 | 2023-2025 | |
| Therapeuticsmd, INC. | $55.14 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.96 | 2019-2021 | |
| Aspira Women'S Health INC | $47.77 | 2022 | |
| Coopersurgical, INC. | $28.60 | 2021 | |
| Becton, Dickinson and Company | $24.69 | 2024 | Arista Ah Flexitip |
| Amag Pharmaceuticals, INC. | $23.72 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $23.50 | 2021 | |
| Allergan, INC. | $23.08 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.77 | 2019 | |
| Olympus America INC. | $14.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benny Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.